GTBP 净利润历史(2016–2025)
GT BIOPHARMA, INC. (GTBP) 年度净利润历史(来自 SEC 财报)—— 每个财年的申报值与同比变化。
-$28.4MFY2025 · FY2016 以来:$9.8M → -$28.4M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | -$28.4M | -115.4% |
| FY2024 | -$13.2M | -73.3% |
| FY2023 | -$7.6M | +63.6% |
| FY2022 | -$20.9M | +64.0% |
| FY2021 | -$58.0M | -105.0% |
| FY2020 | -$28.3M | +26.8% |
| FY2019 | -$38.6M | +85.1% |
| FY2018 | -$259.2M | -79.8% |
| FY2017 | -$144.2M | -1576.0% |
| FY2016 | $9.8M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议